Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).

Publisher Website
Google Scholar
Abstract
It has recently been recognized that human serum contains a protein that specifically binds human growth hormone (hGH). This protein has the same restricted specificity for hGH as the membrane-bound GH receptor. To determine whether the GH-binding protein is a derivative of, or otherwise related to, the GH receptor, we have examined the serum of three patients with Laron-type dwarfism, a condition in which GH refractoriness has been attributed to a defect in the GH receptor. The binding of 125I-labeled hGH incubated with serum has been measured after gel filtration of the serum through an Ultrogel AcA 44 minicolumn. Nonspecific binding was determined when 125I-hGH was incubated with serum in the presence of an excess of GH. Results are expressed as percent of specifically bound 125I-hGH and as specific binding relative to that of a reference serum after correction is made for endogenous GH. The mean .+-. SEM of specific binding of sera from eight normal adults (26-46 years of age) was 21.6 .+-. 0.45%, and the relative specific binding was 101.1 .+-. 8.6%. Sera from 11 normal children had lower specific binding of 12.5 .+-. 1.95% and relative specific binding of 56.6 .+-. 9.1%. Sera from three children with Laron-type dwarfism lacked any demonstrable GH binding, whereas sera from 10 other children with other types of nonpituritary short stature had normal relative specific binding. We suggest that the serum GH-binding protein is a soluble derivative of the GH receptor. Measurement of the serum GH-binding protein may permit recognition of other abnormalities of the GH receptor.

This publication has 23 references indexed in Scilit: